Administrative Procedures for
Clinical Laboratory Improvement Amendments of 1988
Categorization
Extension without change of a currently approved collection
No
Regular
11/26/2025
Requested
Previously Approved
36 Months From Approved
11/30/2025
450
413
80,430
52,400
542,150
115,750
This information collection helps
support implementation of statutory provisions applicable to
laboratories that conduct testing on human specimens under the
Clinical Laboratory Improvement Amendments of 1988 (CLIA). These
requirements are codified in 42 U.S.C. 263a and implementing
regulations are found in 42 CFR 493.
FDA estimates an increase of 30
responses for requests for CLIA categorization and 7 responses for
waiver application submission based on recent FDA receipt data to
more accurately reflect recent receipts of requests for CLIA
categorization and CLIA waiver application submissions. Our total
burden for this collection will be 80,430 hours (24,430 reporting +
56,000 recordkeeping). Our estimated burden for the information
collection reflects an overall increase of 28,030 hours
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.